Aegerion Pharmaceuticals Issued Patent by European Patent Office
Posted on November 28, 2012 at 07:28 AM EST
Aegerion Pharmaceuticals (NASDAQ: AEGR ), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat debilitating and often fatal rare diseases, announced today the issuance by the European Patent Office of Patent No. EP1725234 for a method of treating hyperlipidemia or hypercholesterolemia, including severe